These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1824566)

  • 21. Differential immune complex deposition in mild and severe drug-induced cutaneous reactions.
    Hashizume H; Ishikawa Y; Hata A
    J Dermatol; 2024 Jun; 51(6):e201-e202. PubMed ID: 38214541
    [No Abstract]   [Full Text] [Related]  

  • 22. Fixed drug eruption: state of the art.
    Ozkaya E
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):181-8. PubMed ID: 18076661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation of T lymphocytes in cutaneous allergic reactions to drugs.
    González FJ; Leyva L; Posadas S; Luque I; Blanca M; Santamaría L; Juarez C
    Clin Exp Allergy; 1998 Sep; 28 Suppl 4():3-6. PubMed ID: 9761022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocompetent cells of fixed drug eruption.
    Visa K; Käyhkö K; Stubb S; Reitamo S
    Acta Derm Venereol; 1987; 67(1):30-5. PubMed ID: 2436411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced cutaneous pathology.
    Ramdial PK; Naidoo DK
    J Clin Pathol; 2009 Jun; 62(6):493-504. PubMed ID: 19155238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane.
    Gabrielsen TO; Staerfelt F; Thune PO
    Acta Derm Venereol; 1981; 61(5):439-41. PubMed ID: 6172936
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic cutaneous reactions to drugs.
    Bigby M; Stern RS; Arndt KA
    Prim Care; 1989 Sep; 16(3):713-27. PubMed ID: 2529577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
    Kovacic D; Fox M; Reichenberg J
    J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The skin and allergy].
    Merk HF
    Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):507-17. PubMed ID: 9441025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent.
    Jaber SH; Cowen EW; Haworth LR; Booher SL; Berman DM; Rosenberg SA; Hwang ST
    Arch Dermatol; 2006 Feb; 142(2):166-72. PubMed ID: 16490844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mucous membrane involvement in the course of autoimmune blistering skin diseases and drug eruptions. Differential diagnosis].
    Narbutt J; Sysa-Jedrzejowska A; Kwiecien A
    Przegl Lek; 2004; 61(7):813-7. PubMed ID: 15792028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adverse cutaneous reactions to drugs in neurology].
    Redondo Bellón P
    Rev Neurol; 1997 Sep; 25 Suppl 3():S309-19. PubMed ID: 9273176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
    Adachi A; Nagai H; Horikawa T
    Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of cutaneous drug reactions].
    Yawalkar N; Pichler WJ
    J Dtsch Dermatol Ges; 2004 Dec; 2(12):1013-23; quiz 1024-6. PubMed ID: 16285316
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible anergy after generalized orally elicited allergic contact dermatitis to corticosteroid.
    Thong HY; Yokota M; Chan H; Maibach HI
    Contact Dermatitis; 2008 Feb; 58(2):126-8. PubMed ID: 18186763
    [No Abstract]   [Full Text] [Related]  

  • 37. Pattern analysis of drug-induced skin diseases.
    Justiniano H; Berlingeri-Ramos AC; Sánchez JL
    Am J Dermatopathol; 2008 Aug; 30(4):352-69. PubMed ID: 18645307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
    Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH
    J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alarm signs in drug-induced skin reactions].
    Schmied-Dufour C; Schmied E
    Ther Umsch; 1993 Jan; 50(1):20-2. PubMed ID: 8378862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factitial panniculitis.
    Sanmartín O; Requena C; Requena L
    Dermatol Clin; 2008 Oct; 26(4):519-27, viii. PubMed ID: 18793986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.